Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Tecvayli


Teclistamab-cqyv injection is used to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma in patients who have received at least 4 previous treatment. These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.

This medicine is available only under a restricted distribution program called Tecvayli® and Talvey® REMS (Risk Evaluation and Mitigation Strategy) Program.

This product is available in the following dosage forms:

  • Solution